When it Comes to Drug Pricing, it’s Time for Patients to Stand Up and Be Counted!
Recently, the Institute for Clinical and Economic Review (ICER), released a scoping document outlining its intentions to evaluate the cost effectiveness of drugs used to treat the autoimmune disease Rheumatoid…